Danofloxacin mesylate Good Manufacturer supply High Quality 119478-55-6
- Molecular Formula:C19H20FN3O3.CH4O3S
- Molecular Weight:453.48
- Appearance/Colour:Crystalline solid
- Vapor Pressure:8.41E-14mmHg at 25°C
- Melting Point:337-339 °C
- Boiling Point:569.3 °C at 760 mmHg
- Flash Point:298.1 °C
- PSA：128.53000
- LogP:2.65410
Danofloxacin mesylate (119478-55-6) Usage
Danofloxacin is a fluoroquinolone antibiotic. In vitro, danofloxacin has activity against 68 field isolates of Mycoplasma species isolated from cattle, swine, and poultry with MICs ranging from 8 to 500 nM. It is protective in vivo against P. multocida, E. coli, and S. choleraesuis in mice with protective doses of 0.31, 0.40, and 2.42 mg/kg, respectively. Formulations containing danofloxacin are widely used to prevent infectious disease in livestock.
How to get the best price on Danofloxacin mesylate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Danofloxacin mesylate . You can buy high quality, low price Danofloxacin mesylate 119478-55-6 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
